Journal of Medical Mycology

Aims & Scope

The Journal de Mycologie Medicale / Journal of Medical Mycology (JMM) publishes in English works dealing with human and animal mycology.

The subjects treated are focused in particular on clinical, diagnostic, epidemiological, immunological, medical, pathological, preventive or therapeutic aspects of mycoses.

Also covered are basic aspects linked primarily with morphology (electronic and photonic microscopy), physiology, biochemistry, cellular and molecular biology, immunochemistry, genetics, taxonomy or phylogeny of pathogenic or opportunistic fungi and actinomycetes in humans or animals.

Studies of natural products showing inhibitory activity against pathogenic fungi cannot be considered without chemical characterization and identification of the compounds responsible for the inhibitory activity.

JMM publishes (guest) editorials, original articles, reviews (and minireviews), case reports, technical notes, letters to the editor and information.

Only clinical cases with real originality (new species, new clinical present action, new geographical localization, etc.), and fully documented (identification methods, results, etc.), will be considered.

Under no circumstances does the journal guarantee publication before the editorial board makes its final decision.

The journal is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey platforms.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.8
2024	2.20

SJR (SCImago Journal Rank)

Year	Value
2024	0.429

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	46

Journal Rank

Year	Value
2024	13137

Journal Citation Indicator

Year	Value
2024	435

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Invasive fungal diseases during COVID-19: We should be prepared

  Citation: 265

  Authors: J.-P., M.-E., E., M., J.R.

• Antifungal efficacy of thymol, carvacrol, eugenol and menthol as alternative agents to control the growth of food-relevant fungi

  Citation: 262

  Authors: S., A., H., A.R., A.

• Anti- Candida albicans natural products, sources of new antifungal drugs: A review

  Citation: 139

  Authors: A., S., A., R., R.T.

• Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis

  Citation: 109

  Authors: H., I.

• Green synthesis of gold nanoparticles using Fusarium oxysporum and antibacterial activity of its tetracycline conjugant

  Citation: 107

  Authors: N., P., S.

• Anti- Candida albicans activity of some Iranian plants used in traditional medicine

  Citation: 101

  Authors: A., A.R., M., H., M.

• Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient – Case report and review of literature

  Citation: 93

  Authors: Akshay, Kai-Ming, Ilan, Frances

• Isolation and screening of Streptomyces in soil of protected forest areas from the states of Assam and Tripura, India, for antimicrobial metabolites

  Citation: 93

  Authors: D., A., B.K., T.C.

• The antifungal activity of Moroccan plants and the mechanism of action of secondary metabolites from plants

  Citation: 87

  Authors: F., N., Y.

• Mucormycosis treatment: Recommendations, latest advances, and perspectives

  Citation: 86

  Authors: K., B.

---